Pub. Date : 2016 Jan-Apr
PMID : 27194977
2 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Nilotinib is a second-generation Bcr-Abl tyrosine kinase inhibitor (TKI) that is approved for the treatment of imatinib-resistant chronic myeloid leukaemia expressing the Bcr-Abl mutation. | nilotinib | ABL proto-oncogene 1, non-receptor tyrosine kinase | Homo sapiens |
| 2 | Nilotinib is a second-generation Bcr-Abl tyrosine kinase inhibitor (TKI) that is approved for the treatment of imatinib-resistant chronic myeloid leukaemia expressing the Bcr-Abl mutation. | nilotinib | ABL proto-oncogene 1, non-receptor tyrosine kinase | Homo sapiens |